← Leaderboards
Elizabeth Carey
Mayo Clinic Arizona
$1,129,940
Attributed
$1,129,940
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500K · FY2019–22$500K$375K$250K$125K$0
'19
'20
'21
'22
Funding mix
By agency
FDA$999,994 · 1
NIH$129,946 · 1
By mechanism
R01$999,994 · 1
R21$129,946 · 1
Top collaborators
No co-investigators on record.
Grant awards (3)
A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vancomycin in Adults with Primary Sclerosing Cholangitis$499,996
R01 · FY2022 · FD · contact PI
A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vancomycin in Adults with Primary Sclerosing Cholangitis$499,998
R01 · FY2020 · FD · contact PI
Investigation of the activity of vidofludimus calcium, a novel, orally available, small molecule inhibitor of dihydroorotate dehydrogenase, as a treatment for primary sclerosing cholangitis (PSC)$129,946
R21 · FY2019 · DK · contact PI